Sequel II | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

40,695 results for “Sequel II”

Trials

View all 36186 →

A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease

242 participants · First posted Apr 4, 2025

Childhood TB Sequel

100 participants · First posted Apr 13, 2022

The Indiana SNAP-Ed Long-term Study Sequel

261 participants · First posted Feb 19, 2018

Drugs

View all 291 →

II-559

II-802

II-399

Organizations

View all 59 →

Sequel Pharmaceuticals, Inc.

United States

Celgene International II SARL

Switzerland

Meiragtx UK II Ltd.

Belgium

News

View all 4159 →

PacBio's Sequel II CNDx Becomes World's First Clinically Approved Long-Read Sequencer in China

PacBio Gains China Regulatory Approval for Clinical-Grade Long-Read Sequencing System

PacBio Partners with Haorui Gene to Expand Long-Read Sequencing Access Across China

Page 1 of 4070